Biogen International GMBH et al v. Stason Pharmaceuticals, Inc. et al > Summary
Court Case Number 8:17-cv-01133
Filing Date Jun 30, 2017
Termination Date Jan 11, 2018
Court California Central District Court
Status Dismissed - Voluntarily
Plaintiff Attorneys
11Biogen
Attorney Name: Li Feng
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen
Attorney Name: Sanya Sukduang
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen
Attorney Name: Alan Jay Weil
Kendall Brill & Kelly LLP
Biogen
Attorney Name: Joshua W. Sussman
Kendall Brill & Kelly LLP
Biogen
Attorney Name: Andrew E. Renison
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen MA Inc.
Attorney Name: Alan Jay Weil
Kendall Brill & Kelly LLP
Biogen MA Inc.
Attorney Name: Joshua W. Sussman
Kendall Brill & Kelly LLP
Biogen MA Inc.
Attorney Name: Andrew E. Renison
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen
Attorney Name: Andrew E. Renison
IPD Analytics
Biogen MA Inc.
Attorney Name: Andrew E. Renison
IPD Analytics
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08759393 | Utilization of dialkylfumarates | Jun 24, 2014 |
| 08399514 | Treatment for multiple sclerosis | Mar 19, 2013 |
| 07803840 | Utilization of dialkylfumarates | Sep 28, 2010 |
| 07619001 | Utilization of dialkylfumarates | Nov 17, 2009 |
| 07320999 | Dimethyl fumarate for the treatment of multiple sclerosis | Jan 22, 2008 |
| 06509376 | Utilization of dialkyfumarates | Jan 21, 2003 |
